In order to launch the second phase of its Research Program on Drug Regulatory Reforms in India, ICRIER organized a Special Roundtable on the ‘Importance of Strong Drug Regulatory Systems’ at New Delhi on November 3, 2015. The goal of this roundtable was to discuss and deliberate upon the following upcoming themes under the research program viz. Clinical trials and new drug approvals and Harmonization of certification standards.
The roundtable began with the Inaugural Address by Dr S Eswara Reddy, Joint Drugs Controller (India), CDSCO, Government of India, followed by a Special Address by Mr Kenneth C Frazier, Chairman and CEO, Merck, USA. The distinguished panelists at the roundtable included Dr Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, Bengaluru; Dr Y K Gupta, Professor & Head, Department of Pharmacology, AIIMS, New Delhi; Dr Samir Brahmachari, Chief Mentor, Open Source Drug Discovery; Former Director General, Council of Scientific and Industrial Research (CSIR), New Delhi; Dr Hemant Koshia, Commissioner, Food and Drugs Control Administration, Gujarat and Dr Ratna Devi, CEO, Dakshama Health, New Delhi.
List of partcipants-
|2||Pallavi Joshi||Research Associate||Delhi||9999999999|
|3||Priyanka Tomar||Research Assistant||Delhi||9999999999|
|4||Sanchita Sinha||Consulting Editor||Delhi||9999999999|